Heather Wakelee, MD, Stanford University, discusses the pros and cons of different durations of immunotherapy in non-small cell lung cancer (NSCLC) and the future outlook for patient-specific care.

NBA Hall of Famer Dwyane Wade has revealed that he underwent kidney surgery after doctors discovered ... Inspired by his father’s battle with prostate cancer, Wade finally visited a doctor ...

Patients who received an endobronchial valve vs. lung volume reduction surgery had significantly heightened odds for mortality and readmission. Risk adjustment is important in future research on ...

TUESDAY, Jan. 28, 2025 (HealthDay News) -- For patients with advanced emphysema, endobronchial valve placement (EBV) is associated with higher mortality and morbidity compared with lung volume ...

The VA Health Care System is an integrated network that provides medical services to U.S. military veterans. Approximately 15,000 veterans are diagnosed and treated for prostate cancer annually at ...

Chemotherapy for lung cancer is used for different purposes depending on the type and stage of cancer you have. This includes achieving cancer remission, shrinking a tumor before surgery, killing ...

Non-small cell lung cancer (NSCLC ... and other sources to kill cancer cells and shrink tumors. For NSCLC, radiation can be used in one of four ways: adjuvant therapy (treating remaining cancer cells ...

The type of cancer was not disclosed by Kensington Palace in order to keep the Princess' personal health and medical records private. The reasons for Princess Kate's major abdominal surgery ...

A great-grandmother who had a lifelong phobia about her eyes being touched has undergone surgery for cataracts - and is now looking forward to seeing Wet Wet Wet's Marti Pellow perform without ...

The five-year relative survival rate of small cell lung cancer—the odds that a cancer patient will live another five years compared to a non-patient—ranges from 7% to 30% depending on the ...

In separate, live virtual events, Vincent K. Lam, MD, and Chul Kim, MD, MPH, discuss molecular assays and treatment options for a patient with metastatic non–small cell lung cancer (NSCLC), with ...

Abenacianine received fast track designation for lung cancer surgery, the combination of amivantamab and Lazertinib showed OS improvement in NSCLC, and sunvozertinib has been granted priority review ...